Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives

Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
Conditions:   Breast Carcinoma;   Deleterious CDH1 Gene Mutation;   Deleterious DICER1 Gene Mutation;   Deleterious SMARCA4 Gene Mutation;   Deleterious STK11 Gene Mutation;   Endometrial Carcinoma;   Fallopian Tube Carcinoma;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions:   Other: Interview;   Other: Questionnaire Administration;   Other: Survey Administration
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 6, 2020 / by / in
Comments